pharmaceutical investing Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
pharmaceutical investing Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia
VanadiumCorp Completes Soil Geochemical Survey at its Lac Laura Gold-Copper Property; 314 Samples Submitted to AGAT Laboratories for Analysis
New Break Drills 5.28 g/t Au over 11.2 Metres and 3.95 g/t Au over 14.0 Metres Delivering Further Strong Results at Its Moray Gold Project
